BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4446099
Number of visits today
2870
Number of downloads
4076540
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Meng X, Gao JZ, Gomendoza SMT, Li JW, Yang S. Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Front Med (Lausanne) 2021;8:737951. [PMID: 34671620 DOI: 10.3389/fmed.2021.737951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nagourney AJ, Gipoor JB, Evans SS, D’amora P, Duesberg MS, Bernard PJ, Francisco F, Nagourney RA. Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants. Genes 2023;14:747. [DOI: 10.3390/genes14030747] [Reference Citation Analysis]
2 Li S, Zhang H, Liu J, Shang G. Targeted therapy for osteosarcoma: a review. J Cancer Res Clin Oncol 2023. [PMID: 36807762 DOI: 10.1007/s00432-023-04614-4] [Reference Citation Analysis]
3 Carlsen L, El-deiry WS. Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation. Front Oncol 2022;12:998388. [DOI: 10.3389/fonc.2022.998388] [Reference Citation Analysis]
4 Porter VL, Marra MA. The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers. Cancers 2022;14:4623. [DOI: 10.3390/cancers14194623] [Reference Citation Analysis]
5 Lei R, Zhou M, Zhang S, Luo J, Qu C, Wang Y, Guo P, Huang R. Potential role of PRKCSH in lung cancer: bioinformatics analysis and a case study of Nano ZnO. Nanoscale 2022;14:4495-510. [PMID: 35254362 DOI: 10.1039/d1nr08133k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345